Holiday Hours:
Monday, December 24th & Monday, December 31st – Closing at 4pm
Tuesday, December 25th & Tuesday, January 1st – Office Closed

    • APRIL 1, 2014
    • 0

    Ceritinib Highly Active in Advanced ALK-Positive NSCLC

    By tstorla The investigational compound ceritinib (LDK378) was highly active in patients with advanced ALK-positive non-small cell lung cancer, according to the results of a study published in the New England Journal of Medicine. Lung cancer is the leading cause of cancer death in the U.S. and around the world. Up to 7 percent of

    Read more
    • MARCH 25, 2014
    • 0

    Let’s Leave Out The Word “Cancer”

    Cancer is perhaps the most frightening word a patient can hear. In a recent interview, Dr. Otis Brawley, chief medical officer for the American Cancer Society, discussed redefining cancer to reduce unnecessary treatment. The issue has been raised before but there is new emphasis on the problem. The two best examples are in breast and

    Read more